ÂÜÀòÂÒÂ×

John Weinberg, MD, MBA, is an experienced biotechnology and pharmaceutical executive with a diverse background in clinical development, strategic operations, and consultancy. Currently serving as an Advisory Board Member at NG Bio and Chief Medical Officer at Pure Biologics, Weinberg has previously held leadership positions, including Founder & CEO at Sandton BioConsulting and Chief Medical Officer at MaaT Pharma and 4D Pharma PLC. With a track record of advancing oncology and immunology therapies, Weinberg's expertise spans from managing global operations at Veloxis Pharmaceuticals to directing the Transplant and Infectious Disease franchise at Novartis. An MBA graduate from INSEAD and a Doctor of Medicine from the University of the Witwatersrand, Weinberg continues to impact clinical development and commercialization in the biopharmaceutical industry.